This book presents current research in the study of various cancer treatments. Topics discussed include anticancer drugs and anticancer agents; design of novel anticancer drugs; aromatase inhibitors; aromatase inhibitors for the medical treatment of endometriosis; the use of aromatase inhibitors in ovarian cancer and identification of responsive tumours; inherent and microenvironment-mediated mechanisms of drug resistance; targeting adverse features of hormone-resistant breast cancer; systematic analysis of patterns of cross resistance between anticancer agents and treating drug resistant malignancy.
Preface; Micro- & Nano-Particulate Drug Delivery Systems for Cancer Treatment; Geldanamycin Derivatives as Promising Anticancer Drugs:: Therapy via Hsp90 Inhibition; Synergistic Antitumor Activity of Metronomic Dosing Chemotherapy in Combination with Liposomal Anticancer Drug; Organotin Polyethers as Anticancer Drugs; Studies on Anticancer Agents:: Phenolic Compounds & their Pharmacological Activity; Design of Novel Anticancer Drugs Utilizing Busulfan for Optimizing Pharmacological Properties & Pattern Recognition Techniques for Elucidation of Clinical Efficacy; Analysis of Associations Among Novel Property Descriptors & their Capacity in Determining Clinical Efficacy by Utilizing Pattern Recognition Technigues ; Insights into the Mode of Action of Investigational Ruthenium(III) Cytotoxins from Electrochemical & Biological Studies; Marina Crystal Minerals(MCM) Induce Apoptosis of Human Metastatic Breast Cancer MDA-MB-231 Cells In Vitro; Anti-Estrogen Agents:: Aromatase Inhibitors; Past, Present & Future; Aromatase Inhibitors:: Types, Mode of Action & Indications; Aromatase Inhibitors.
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.